PLSE Q3 2023 Earnings — Pulse Biosciences, Inc. Revenue & Financial Results | Market Cap Arena

PLSEPulse Biosciences, Inc.

$1B

Q3 2023 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$11M

Net Income

-$11M

EPS (Diluted)

$-0.19

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$10M

Free Cash Flow

-$11M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$66M

Total Liabilities

$14M

Stockholders' Equity

$52M

Cash & Equivalents

$50M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	-$8M	+100.0%
Operating Income	-$11M	-$18M	+37.6%
Net Income	-$11M	-$18M	+41.4%